In The News

This section of the Foundation’s website is a resource area for journalists and anyone looking for background information on prostate cancer and Prostate Cancer Canada. This section also provides all press releases issued by the Foundation.

Click the links below for more information on:


For more information about Prostate Cancer Canada, or to arrange an interview with a urologist, prostate cancer survivor, or the Foundation’s President & CEO, please contact:

Adam Miller
Manager, Communications
Prostate Cancer Canada
416 441 2131 ext. 235

adam.miller@prostatecancer.ca
 

News Releases

Prostate Cancer Canada Partners with Screw Cancer™

TORONTO, ON - Starting today, you can screw cancer and give hope in your local community by purchasing the Screw Cancer™ screwdriver in support of Prostate Cancer Canada. The Screw Cancer™ campaign is partnering with Prostate Cancer Canada, as well as the Sunnybrook Hospital Foundation (Toronto, ON), the Juravinski Hospital and Cancer Centre Foundation (Hamilton, ON) , the Thunder Bay Regional Health Sciences Foundation, the Northern Cancer Foundation (Sudbury, ON) and the Grand River Hospital Foundation (Kitchener-Waterloo, ON) to raise funds for research into improved diagnostics and treatments, as well as support services and resources at the community level. The campaign is designed to give you, the donor, the power to choose which local support organization your donation will support when you purchase a screwdriver to #screwcancer.

Indy Cycling Challenge at Exhibition Place Announced to Support Prostate Cancer Canada

TORONTO (January 24, 2017) – Cycling enthusiasts have the opportunity to band together for a great cause while experiencing the Honda Indy Toronto like never before.  Teams composed of four riders each can register now to compete in the Indy Cycling Challenge held on July 13, 2017, on the 2.89km temporary race circuit at Exhibition Place.

Scientists identify DNA signature linked to prostate cancer severity

January 9, 2017 – TORONTO, ON – The Canadian Prostate Cancer Genome Network (CPC-GENE) has published findings from the world’s most comprehensive genetic analysis of prostate cancer tumours in the journal Nature. Led by Drs. Robert Bristow of the Princess Margaret Cancer Centre and Paul Boutros of the Ontario Institute for Cancer Research, CPC-GENE has uncovered the full set of mutations that can occur in the most common cancer in men. By fully cataloging these mutations, the CPC-GENE team was able to create a new signature that predicts at an early stage whether a prostate cancer tumour will become aggressive or not, allowing for personalized treatment. 

BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer. Funded by Prostate Cancer Canada and led by Dr. Robert Bristow of the Princess Margaret Cancer Centre in Toronto, the findings were published today in Nature Communications: 

Thank You to our Canadian Mo Bros and Sistas!

TORONTO, December 1, 2016 - Prostate Cancer Canada congratulates the more than 500,000 Mo Bros and Mo Sistas worldwide who participated in this year's Movember campaign. Here in Canada, enthusiasm was on display in many forms, from spirited move challenges like 24-hour runs and epic host events like Suits & Staches in Toronto, to the first ever online host event of 24-hour gaming streams with EA Sports and over 60,000 official moustaches. 

The Parking Lot Prostate Exam Project #TalkProstate

To stimulate public discussion about prostate cancer and the importance of early detection, Prostate Cancer Canada teamed up with FCB Canada and CFL legend Damon Allen during Prostate Cancer Awareness Month to help get a serious message across through a fun campaign.

Interpreting the study on early prostate cancer survival with Urologist and prostate cancer expert, Dr. Fred Saad

Toronto, ON – September 19, 2016: A study published last week in the New England Journal of Medicine followed men with localized (contained to the prostate) prostate cancer for 10 years as they underwent one of three randomized treatment streams has since been widely reported on. Notably, many of the headlines touched upon the same reassuring conclusion: whether participants were treated with radiation therapy, had their prostates removed altogether, or were simply monitored using Prostate-Specific Antigen (PSA) tests, survival after ten years was the same at 99 per cent.

The future of prostate cancer research looks bright

Toronto, ON – September 19, 2016:  Continuing with its ongoing commitment to ensure the future of prostate cancer research in Canada is left in the best possible hands, Prostate Cancer Canada (PCC) has chosen four postdoctoral fellows and one PhD candidate as the recipients for this year’s prestigious personnel awards.  

Plaid for Dad becoming a Canadian Father's Day tradition

July 8, 2016 – TORONTO, ON – In only its second year, Prostate Cancer Canada’s (PCC) Plaid For Dad campaign further solidified itself as the way Canadians are choosing to give back each Father’s Day weekend. Growing from 200 to over 600 participating workplaces across the country, the number of Canadians who wore plaid to raise awareness and research funds for prostate cancer rose significantly in just a year’s time.  

A Walk to Remember

CALGARY, ALBERTA – June 20th, 2016 – Friends, families and survivors from across the country joined Prostate Cancer Canada this Father’s Day, unified by one goal – to raise funds and awareness for prostate cancer.   Team Eberle, led by Jordan Eberle of the Edmonton Oilers, show their enthusiasm at the Calgary Walk Run.

Displaying results 1-10 (of 117)
 |<  < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >| 




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada Partners with Screw Cancer™

TORONTO, ON - Starting today, you can screw cancer and give hope in your local community by purchasing the Screw Cancer™ screwdriver in support of Prostate Cancer Canada.
More

Indy Cycling Challenge at Exhibition Place Announced to Support Prostate Cancer Canada

TORONTO (January 24, 2017) – Cycling enthusiasts have the opportunity to band together for a great cause while experiencing the Honda Indy Toronto like never before.
More

BRCA2 gene implicated in rare but lethal prostate cancer

January 9, 2017 – TORONTO, ON – Canadian scientists have discovered a link between an inherited mutation in the BRCA2 gene and a deadly form of prostate cancer.
More


Click here for news archive